News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed an advanced artificial intelligence (AI)-driven tool to improve the management and prognosis of prostate cancer. Recent ...

Figures from Prostate Cancer UK suggest about one in eight men will have this disease in their lifetime. A total of 58,218 ...

FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results. FDA-authorized artificial intelligence (AI) ...

In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...

An AI-powered service for prostate cancer which can spot lesions in minutes will be trialled in the NHS to help speed up diagnosis for men.

NHS hospitals are set to test an artificial intelligence tool, ArteraAI Prostate Biopsy Assay, designed to diagnose and guide treatment decisions for prostate cancer.

Editor's note: The Larger Trend section has been updated. California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo ...

It’s not always an easy conversation for men to have, but talking about prostate problems is a critical part of staying ...

Artificial Intelligence will be harnessed to find hidden cases of prostate cancer, the Science Secretary has said. Peter Kyle told The Telegraph that the Government is investing £168m on initiatives ...

Thanks to early detection and aggressive treatment for prostate cancer, 97 percent of all men diagnosed with the disease will survive at least 5 years and nearly 80 percent will survive at least a ...